“…The functionalization of dodecaborates has attracted much attention, both for the development of boron neutron capture therapy (BNCT),[1] where 10 B nuclei capture thermal neutrons to emit 7 Li nuclei and alpha particles that destroy cancer cells. Increasing focus has been placed on the conjugation of the thiol‐substituted B 12 ‐cluster mercaptoundecahydro‐ closo ‐dodecaborate (Na 2 [B 12 H 11 SH]; BSH)[2] with biomolecules (eg, porphyrins,[3] nitroimidazoles,[4] sugars,[5] chlorins,[3b,16] and lipids[7]) by thiol derivatization. This is mostly due to the fact that BSH offers great biological advantages relative to the related dicarba‐ closo ‐dodecaborane (C 2 B 10 H 12 ; “carborane”) analogues, which includes higher boron content, ionic nature, higher solubility in water, significantly lower toxicity based on its boron content, and its clinical use in the treatment of cancer (BNCT) [1a].…”